We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Resect and Discard Strategy in Clinical Practice

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01462123
Recruitment Status : Completed
First Posted : October 31, 2011
Last Update Posted : October 31, 2011
Information provided by:
Valduce Hospital

Brief Summary:

Nowadays, post-polypectomy surveillance intervals are determined by combining endoscopic and pathologic data. Real-time imaging technologies, have shown promising results in discriminating adenomatous from non-adenomatous polyps.

The "resect and discard strategy" for small polyps (based on real-time assessment of the histology and on the endoscopic resection without pathological examination) has been shown to be cost-effective in simulation models. No data exist about the impact of this strategy in clinical practice.

The aim of present study was to assess whether the systematic use, in the everyday clinical practice, of the "resect and discard strategy" allows to correctly manage patients with small colonic polyps.

Condition or disease Intervention/treatment
Endoscopic Assessment Colonic Polyps Endoscopic Surveillance NBI Other: endoscopic assessment of colonic polyps

Study Type : Observational
Actual Enrollment : 286 participants
Time Perspective: Prospective
Study Start Date : February 2011

Resource links provided by the National Library of Medicine

U.S. FDA Resources

Group/Cohort Intervention/treatment
small polyps patients
Patients with one small polyps at colonoscopy
Other: endoscopic assessment of colonic polyps

Primary Outcome Measures :
  1. The primary outcome of the study was to assess the agreement between "endoscopy-" and "histology-determined" surveillance strategies after small adenoma resection.

Secondary Outcome Measures :
  1. sensitivity of the endoscopic assessment (WL coupled with NBI) of small (<10 mm) adenomas
  2. operative characteristics for the diagnosis of diminutive (< 5 mm) adenomas
  3. the feasibility of non histologic evaluation, represented by the proportion of polyps in which a in-vivo diagnosis of adenoma can be made with high confidence
  4. specificity of the endoscopic assessment
  5. accuracy of the endoscopic assessment

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Ages Eligible for Study:   18 Years to 80 Years   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population
Consecutive adult outpatients undergoing colonoscopy for routine clinical indications

Inclusion Criteria:

  • consecutive adult outpatients undergoing colonoscopy for routine clinical indications

Exclusion Criteria:

  • surveillance interval was not necessarily directed by endoscopic findings (history of colorectal cancer, inflammatory bowel disease, hereditary polyposis syndromes, hereditary non-polyposis colorectal cancer)
  • colonoscopy was performed without NBI technology
  • at least one lesion > 10 mm or < 10 mm but with morphologic features suspect for malignancy (depressed or ulcerated lesions) was detected
  • bowel preparation was inadequate
  • caecal intubation was not accomplished
  • polyps could not be resected for concomitant anticoagulation treatment, 7) polyps were resected but not retrieved for pathology.

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01462123

Valduce Hospital - Gastroenterology Department
Como, CO, Italy, 2100
Sponsors and Collaborators
Valduce Hospital

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
ClinicalTrials.gov Identifier: NCT01462123     History of Changes
Other Study ID Numbers: RD 2010
First Posted: October 31, 2011    Key Record Dates
Last Update Posted: October 31, 2011
Last Verified: October 2011

Additional relevant MeSH terms:
Colonic Polyps
Intestinal Polyps
Pathological Conditions, Anatomical